Seeing Is Believing
with an average price target of $6.94. This is a potential upside of $6.94 (0%) from yesterday's end of day stock price of $0.
Momenta Pharmaceuticals's activity chart (see below) currently has 97 price targets and 61 ratings on display.
Analysts average stock forecasts to be materialized ratio is 96.11% with an average time for these price targets to be met of 264.87 days.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 25-Aug-2020. First documented stock forecast 17-Apr-2015.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 31-Jan-2017
$50
5 years 4 months 21 days ago
(25-Aug-2020)
11/11 (100%)
$19.95 (66.39%)
190
Hold
Since 24-Aug-2020
$45
5 years 4 months 22 days ago
(24-Aug-2020)
7/7 (100%)
$20.74 (85.49%)
287
Hold
Since 20-Aug-2020
$47
5 years 4 months 26 days ago
(20-Aug-2020)
5/5 (100%)
$18.45 (64.62%)
320
Hold
Since 07-Nov-2018
$38
5 years 4 months 26 days ago
(20-Aug-2020)
3/3 (100%)
$1.53 (4.20%)
124
Hold
Since 19-Aug-2020
$42
$-10.48 (-19.97%)
$42
5 years 4 months 27 days ago
(19-Aug-2020)
3/4 (75%)
$-10.12 (-19.42%)
27
What is MNTA (Momenta Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MNTA (Momenta Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MNTA (Momenta Pharmaceuticals)?
Which analyst is the currently most bullish on MNTA (Momenta Pharmaceuticals)?
Which analyst is the currently most reserved on MNTA (Momenta Pharmaceuticals)?